RU99101827A - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES - Google Patents
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASESInfo
- Publication number
- RU99101827A RU99101827A RU99101827/14A RU99101827A RU99101827A RU 99101827 A RU99101827 A RU 99101827A RU 99101827/14 A RU99101827/14 A RU 99101827/14A RU 99101827 A RU99101827 A RU 99101827A RU 99101827 A RU99101827 A RU 99101827A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- viral diseases
- treatment
- benzylbenzimidazole
- immunomodulator
- Prior art date
Links
- 208000001756 Virus Disease Diseases 0.000 title claims 2
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- CJTQARUHALKPGG-UHFFFAOYSA-N 2-benzyl-1H-benzimidazole;hydron;chloride Chemical compound Cl.N=1C2=CC=CC=C2NC=1CC1=CC=CC=C1 CJTQARUHALKPGG-UHFFFAOYSA-N 0.000 claims 2
- LLEUXCDZPQOJMY-AAEUAGOBSA-N Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(O)=O)=CNC2=C1 LLEUXCDZPQOJMY-AAEUAGOBSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 239000002955 immunomodulating agent Substances 0.000 claims 2
- 230000002584 immunomodulator Effects 0.000 claims 2
- 229940121354 immunomodulators Drugs 0.000 claims 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 2
- 108010016626 Dipeptides Proteins 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Claims (1)
Гидрохлорид 2-бензилбензимидазола - 0,004 - 0,040
Аскорбиновая кислота - 0,025-0,100
Мононатриевая соль L-глутамил-L-триптофана - 0,0005 - 0,005A pharmaceutical composition for treating viral diseases, including 2-benzylbenzimidazole hydrochloride, ascorbic acid and an immunomodulator dipeptide, characterized in that as an immunomodulator the composition contains a monosodium salt of L-glutamyl-L-tryptophan in the following ratio of components in a single dosage unit, g:
2-benzylbenzimidazole hydrochloride - 0.004 - 0.040
Ascorbic acid - 0,025-0,100
Monosodium salt of L-glutamyl-L-tryptophan - 0.0005 - 0.005
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99101827/14A RU2165254C2 (en) | 1999-01-20 | 1999-01-20 | Pharmaceutical composition for treatment of viral diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99101827/14A RU2165254C2 (en) | 1999-01-20 | 1999-01-20 | Pharmaceutical composition for treatment of viral diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU99101827A true RU99101827A (en) | 2001-02-20 |
| RU2165254C2 RU2165254C2 (en) | 2001-04-20 |
Family
ID=20215301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU99101827/14A RU2165254C2 (en) | 1999-01-20 | 1999-01-20 | Pharmaceutical composition for treatment of viral diseases |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2165254C2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2445965C2 (en) * | 2010-07-05 | 2012-03-27 | Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") | Oral pharmaceutical composition for treating inflammatory gastrointestinal diseases |
| RU2438694C1 (en) | 2010-12-23 | 2012-01-10 | Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") | Pharmaceutical composition for treatment of viral diseases |
| WO2013055251A1 (en) | 2011-10-14 | 2013-04-18 | Общество С Ограниченной Ответственностью "Цитонир" | Oral pharmaceutical composition for the treatment of inflammatory gastrointestinal diseases |
-
1999
- 1999-01-20 RU RU99101827/14A patent/RU2165254C2/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE447947T1 (en) | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE | |
| RU94013439A (en) | HETEROCYCLIC COMPOUNDS, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | |
| DE60126980D1 (en) | THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC ILLNESSES | |
| DE69433818D1 (en) | COMBINED ACTIVE SUBSTANCES AS A METHOD FOR TARGETED ACTIVE SUBSTANCE RELEASE | |
| BR9510168A (en) | Polyamino acid compound composition unit dosage form and method for preparing a composition | |
| TR199901132T2 (en) | To inhibit the release and/or synthesis of β-amyloid peptide using N-(aryl/heteoaryl) amino acid derivatives, pharmaceutical compositions containing them, and such compounds for methods. | |
| DE69727956D1 (en) | PHARMACEUTICAL PREPARATIONS FOR REDUCING BREATHING DEPRESSIONS | |
| SI1546127T1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| DE3650358D1 (en) | Pharmaceutical compositions containing diphosphonates for the treatment of arthrosis. | |
| DE60233433D1 (en) | PHARMACEUTICAL PREPARATION containing a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES | |
| RU95112456A (en) | Derivatives of n-(3-piperidinylcarbonyl)-beta-alanine as antagonists of platelet activation factor, method of synthesis, pharmaceutical composition and method of treatment | |
| DE60135904D1 (en) | DRUGS FOR THE TREATMENT OF NERVE DISEASES | |
| EA199800717A1 (en) | METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION | |
| DE69420229T2 (en) | Pharmaceutical composition for the treatment of AIDS | |
| RU99101827A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | |
| DE69925578D1 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES RELATED TO EYE-BASED CELL-DISEASES | |
| RU2002135669A (en) | OLIGOPEPTIDES | |
| ATE404192T1 (en) | USE OF NEFIRACETAM TO TREAT POSTISCHEMIC NEURODEGENERATION | |
| CA2290739A1 (en) | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
| ATE302011T1 (en) | PONAZURIL FOR THE TREATMENT OF DISEASES CAUSED BY COCCIDIA NEUROLOGICAL AND ABORTIGENICS | |
| RU94045140A (en) | Pharmaceutical composition for prophylaxis and treatment of viral diseases, method of its preparing and use of bradykinin antagonist or its physiologically tolerant salt as agent for prophylaxis and treatment of viral diseases | |
| TR200200111T2 (en) | Therapeutic and prophylactic agents for neoplasms | |
| RU95102718A (en) | Method of immune status correction in hiv-infected patients | |
| RU97111543A (en) | METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION | |
| DE29501910U1 (en) | Transdermal therapeutic system containing the active ingredient dimethisoquine |